1. A 3-weekly schedule of irinotecan and panitumumab for wild-type KRAS metastatic colorectal cancer. (April 2014) Authors: Hansen, Torben Frøstrup; Andersen, Rikke Fredslund; Pallisgaard, Niels; Spindler, Karen-Lise Garm; Pløen, John; Keldsen, Nina; Lindebjerg, Jan; Sørensen, Flemming Brandt; Jakobsen, Anders Journal: Colorectal cancer Issue: Volume 3:Number 2(2014) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery. Issue 4 (4th February 2015) Authors: Reinert, Thomas; Schøler, Lone V; Thomsen, Rune; Tobiasen, Heidi; Vang, Søren; Nordentoft, Iver; Lamy, Philippe; Kannerup, Anne-Sofie; Mortensen, Frank V; Stribolt, Katrine; Hamilton-Dutoit, Stephen; Nielsen, Hans J; Laurberg, Søren; Pallisgaard, Niels; Pedersen, Jakob S; Ørntoft, Torben F; Ander... Journal: Gut Issue: Volume 65:Issue 4(2016) Page Start: 625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of droplet digital polymerase chain reaction for measuring BCR‐ABL1 in chronic myeloid leukaemia in an international interlaboratory study. (10th June 2021) Authors: Scott, Stuart; Cartwright, Ashley; Francis, Sebastian; Whitby, Liam; Sanzone, A. Pia; Mulder, André; Galimberti, Sara; Dulucq, Stephanie; Mauté, Carole; Lauricella, Calogero; Salmon, Matthew; Rose, Susan; Willoughby, Josh; Boeckx, Nancy; Pallisgaard, Niels; Maier, Jacqueline; Leibundgut, Elisabet... Journal: British journal of haematology Issue: Volume 194:Number 1(2021) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bridging blood cancers and inflammation: The reduced Cancitis model. (21st March 2019) Authors: Ottesen, Johnny T.; Pedersen, Rasmus K.; Sajid, Zamra; Gudmand-Hoeyer, Johanne; Bangsgaard, Katrine O.; Skov, Vibe; Kjær, Lasse; Knudsen, Trine A.; Pallisgaard, Niels; Hasselbalch, Hans C.; Andersen, Morten Journal: Journal of theoretical biology Issue: Volume 465(2019) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cell‐free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer. Issue 12 (17th June 2014) Authors: Spindler, Karen‐Lise Garm; Appelt, Ane L.; Pallisgaard, Niels; Andersen, Rikke F.; Brandslund, Ivan; Jakobsen, Anders Journal: International journal of cancer Issue: Volume 135:Issue 12(2014:Dec. 15) Page Start: 2984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Changes in mutational status during third‐line treatment for metastatic colorectal cancer—Results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma. Issue 9 (17th April 2014) Authors: Spindler, Karen‐Lise Garm; Pallisgaard, Niels; Andersen, Rikke Fredslund; Jakobsen, Anders Journal: International journal of cancer Issue: Volume 135:Issue 9(2014:Nov. 01) Page Start: 2215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Circulating tumor DNA as a marker of minimal residual disease following local treatment of metastases from colorectal cancer. (1st December 2020) Authors: Boysen, Anders K.; Pallisgaard, Niels; Andersen, Christina S. A.; Spindler, Karen-Lise G. Journal: Acta oncologica Issue: Volume 59:Number 12(2020) Page Start: 1424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapy. Issue 17 (November 2015) Authors: Spindler, Karen-Lise Garm; Pallisgaard, Niels; Appelt, Ane Lindegaard; Andersen, Rikke Fredslund; Schou, Jakob V.; Nielsen, Dorte; Pfeiffer, Per; Yilmaz, Mette; Johansen, Julia S.; Hoegdall, Estrid V.; Jakobsen, Anders; Jensen, Benny V. Journal: European journal of cancer Issue: Volume 51:Issue 17(2015:Nov.) Page Start: 2678 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinicopathological factors associated with tumour‐specific mutation detection in plasma of patients with RAS‐mutated or BRAF‐mutated metastatic colorectal cancer. Issue 6 (20th May 2021) Authors: Hamfjord, Julian; Guren, Tormod Kyrre; Glimelius, Bengt; Sorbye, Halfdan; Pfeiffer, Per; Dajani, Olav; Lingjærde, Ole Christian; Tveit, Kjell Magne; Pallisgaard, Niels; Spindler, Karen‐Lise Garm; Kure, Elin H. Journal: International journal of cancer Issue: Volume 149:Issue 6(2021) Page Start: 1385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Correlation between circulating cell‐free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA‐mutated metastatic breast cancer. Issue 6 (4th May 2018) Authors: Kodahl, Annette R.; Ehmsen, Sidse; Pallisgaard, Niels; Jylling, Anne M. B.; Jensen, Jeanette D.; Lænkholm, Anne‐Vibeke; Knoop, Ann S.; Ditzel, Henrik J. Journal: Molecular oncology Issue: Volume 12:Issue 6(2018) Page Start: 925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗